Showing results (351-360 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|January 25, 2020
Synthesis and validation of [18F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backboneChristian W Wichmann, Yit Wooi Goh, Adam C Parslow, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizationsSally W Schwarz, Clemens Decristoforo
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticalsErik de Blois, Rory M S de Zanger, Ho Sze Chan, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Synthesis of a benzoxazinthione derivative of tanaproget and pharmacological evaluation for PET imaging of PR expressionLouis Allott, Cecilia Miranda, Angela Hayes, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Clinical-grade N-(4-[18F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humansElly L van der Veen, Inês F Antunes, Petra Maarsingh, et al.
EJNMMI Radiopharmacy and Chemistry|June 13, 2025
Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPETMario González-Arjona, Lorena Cussó, Luis Alcalá, et al.
EJNMMI Radiopharmacy and Chemistry|May 30, 2025
Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expressionAnzhelika Vorobyeva, Moeen-Ud Din, Alexey Schulga, et al.
EJNMMI Radiopharmacy and Chemistry|October 3, 2025
Highlight selection of radiochemistry and radiopharmacy developments by editorial boardJun Toyohara, Philipp H Elsinga, Sergio Todde, et al.
EJNMMI Radiopharmacy and Chemistry|September 26, 2025
[11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeuticsRomy Cools, Valeria Narykina, Koen Vermeulen, et al.
EJNMMI Radiopharmacy and Chemistry|July 3, 2025
Exploring the radiochemistry of PARP inhibitors: a new era in therapy and imagingGianluca Destro, Rebecca Rizzo, Chiara Rua, et al.
Pageof 44